These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9352487)

  • 1. Checklist of information usually submitted in an investigational device exemption (IDE) application for refractive surgery lasers. Ophthalmic Devices Advisory Panel, Food and Drug Administration.
    J Refract Surg; 1997; 13(6):579-88. PubMed ID: 9352487
    [No Abstract]   [Full Text] [Related]  

  • 2. Custom excimer users threaten PRK success.
    Moretti M
    J Refract Surg; 1995; 11(5):333-4. PubMed ID: 8528909
    [No Abstract]   [Full Text] [Related]  

  • 3. Home-made excimer lasers are operating today in the US--the rest of the country watches and waits.
    Kremer FB
    J Refract Surg; 1995; 11(5):328. PubMed ID: 8528907
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA takes on maker of "homemade" excimer lasers.
    Kearns LA
    J Refract Surg; 1995; 11(5):331-2. PubMed ID: 8528908
    [No Abstract]   [Full Text] [Related]  

  • 5. Aberration analyses needed for FDA evaluation of safety and effectiveness of wavefront-guided refractive surgical devices.
    Drum BA
    J Refract Surg; 2003; 19(5):S588-91. PubMed ID: 14518749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intense competition shapes PRK delivery market.
    Moretti M
    J Refract Surg; 1995; 11(3):160. PubMed ID: 7553083
    [No Abstract]   [Full Text] [Related]  

  • 7. Excimer laser photorefractive keratectomy. The Food and Drug Administration panel speaks.
    McDonnell PJ
    Arch Ophthalmol; 1995 Jul; 113(7):858-9. PubMed ID: 7605273
    [No Abstract]   [Full Text] [Related]  

  • 8. Draft clinical guidance for the preparation and contents of an Investigational Device Exemption (IDE) application for excimer laser devices used in ophthalmic surgery for myopic photorefractive keratectomy (PRK). Office of Device Evaluation, Division of Ophthalmic Devices, Food and Drug Administration.
    Refract Corneal Surg; 1990; 6(4):265-9. PubMed ID: 2268588
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA begins to act against black box excimer lasers.
    Kohl M
    J Refract Surg; 1997; 13(4):336-8. PubMed ID: 9268930
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulatory considerations regarding the use of the excimer laser for LASIK.
    Matelski WH
    J Refract Surg; 1996; 12(5):572-4. PubMed ID: 8871857
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA panel gives cautious signal to summit.
    Moretti M
    J Refract Corneal Surg; 1994; 10(6):613-4. PubMed ID: 7719529
    [No Abstract]   [Full Text] [Related]  

  • 12. Third Annual Nidek International Excimer Laser User's meeting. Phuket, Thailand. December 6-8, 1997. Proceedings and abstracts.
    J Refract Surg; 1998 Apr; 14(2 Suppl):S173-249. PubMed ID: 9571545
    [No Abstract]   [Full Text] [Related]  

  • 13. Corneal nerve recovery after photorefractive keratectomy and laser in situ keratomileusis.
    Latvala T; Linna T; Tervo T
    Int Ophthalmol Clin; 1996; 36(4):21-7. PubMed ID: 9021456
    [No Abstract]   [Full Text] [Related]  

  • 14. Considering corneal and lenticular techniques of refractive surgery.
    Rosen ES
    J Cataract Refract Surg; 1997 Jun; 23(5):689-91. PubMed ID: 9278780
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA begins to act against unapproved excimer lasers: what took so long?
    Mandle M
    J Refract Surg; 1996; 12(7):753-4. PubMed ID: 8970018
    [No Abstract]   [Full Text] [Related]  

  • 16. Excimer laser refractive surgery in the pediatric population.
    Haw WW; Alcorn DM; Manche EE
    J Pediatr Ophthalmol Strabismus; 1999; 36(4):173-7; quiz 206-7. PubMed ID: 10442722
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA regulation of black box lasers: approximately 50% of users opt to submit investigational device exemptions.
    Mandle M
    J Refract Surg; 1997; 13(2):124-5. PubMed ID: 9109065
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA writes warning letter to users of homemade and illegally imported lasers.
    Waring GO
    J Refract Surg; 1996; 12(5):569-71. PubMed ID: 8871856
    [No Abstract]   [Full Text] [Related]  

  • 19. Consultation section. Refractive surgical problem.
    J Cataract Refract Surg; 1998 May; 24(5):576-80. PubMed ID: 9610436
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality of vision and freedom from optical correction after refractive surgery.
    Waring GO
    J Refract Surg; 1997; 13(3):213-5. PubMed ID: 9183750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.